The Pulmonary Health Study

About this study

Clinical studies take place every day around the world and rely on everyday people who choose to contribute to the future of medicine.

Understanding the study

This study is exploring a potential new therapy aimed at helping slow disease progression and improve outcomes for people living with Idiopathic Pulmonary Fibrosis (IPF).

IPF is a long-term lung condition where the tissue in the lungs slowly becomes scarred and stiff. Normally, your lungs are soft and stretchy, which makes it easy to breathe and for oxygen to pass into your blood. With IPF, scar tissue builds up in the lungs over time, making them thicker and harder. As this scarring increases, it becomes more difficult to breathe and harder for the body to get the oxygen it needs.

The purpose of this study is to evaluate how the experimental drug is processed in the body and to assess potential interactions between the study drug and medications currently approved for IPF.

What participation involves

Here’s what you can expect when you join this clinical study.

Study duration

  • One 7-night stay
  • One 11-night stay
  • 18 nights inpatient in total
  • Daily at-home dosing from Day 7 until Day 20
  • 3 clinic dosing visits
  • 1 follow-up visit

Flexible Start Date: The study coordinator will arrange the exact study dates with you after screening.

  • Study Medication

    Administered via oral tablets

  • Monitored Environment

    Professional clinical setting with continuous care

  • Medical Team Support

    Expert healthcare professionals throughout your participation

  • Compensation Provided

    Reimbursement for your time and commitment

Who may qualify

Specific health criteria help ensure the study is safe and provides meaningful results.

You may qualify to participate if you are:

  • Male (sterile) or female (post-menopausal or sterile)
  • Between 26-65 years old
  • In generally good health
  • Not currently taking long-term prescription medications
  • Healthy weight or healthy weight (BMI 18.5-32 kg/m2)

Compensation

Your time and commitment are valued. Here’s what you can expect.

Up to $10,140

*with screening reimbursement

Full details outlined in consent form.

Participants are paid for their time and involvement. The amount depends on the specific study and reflects the commitment required, including clinic visits and follow-ups. All payment terms are explained clearly before you decide to take part.